UGT1A1*28 Detection Kit(Testing Service)

Relating to Drug: Irinotecan is a cancer therapy drug. UGT1A1 gene promoters usually have 5-8 TA repeat, most people with 6/6 TA repeat, few people are 6/7 or 7/7 TA repeat, 7 TA repeat genotypes were named for the UGT1A1*28.


In 2006, the U.S. FDA added UGT1A1*28 genotype information to the drug label for Irinotecan and to assess the potential value of genotyping of UGT1A1∗28 in patients before starting treatment with irinotecan to reduce the risk of severe toxicity.

Test Method

Product validation by sequencing method and specimen testing by HRM methodology.


Online Enquiry

Satisfying your questions, needs, and requirements is always a priority.
The health of humanity is a responsibility that we will never relinquish.

HTML Snippets Powered By : XYZScripts.com
Scroll to Top